...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Equity financing
9
Jun 06, 2018 06:09PM
2
Jun 07, 2018 09:14AM
2
Jun 07, 2018 04:40PM

Yes, you own shares Zenith Capital Corp (ZCC). The pending offering is also for ZCC shares. The science part of the company, Zenith Epigenetics Ltd (ZEL) is a a wholly-owned subsidiary of ZCC. ZCC also retains its investment in the royalty preferred shares (RPS) of Resverlogix Corp. Shareholders of ZCC have an indirect interest in the RPS but do not own the RPS directly.

BDAZ

2
Jun 07, 2018 05:54PM
5
Jun 25, 2018 01:59PM
3
Jun 25, 2018 03:27PM
5
Jun 25, 2018 09:01PM
Share
New Message
Please login to post a reply